SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-10.1
Date Filed: 2026-03-25
Accession Number: 0001213900-26-034072
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026034072/ea028322301ex10-1.htm

Chunk 45 of 68
Word Count: 1478
Character Count: 9195

Document Content:

continuation statement or amendment with respect thereto, in any appropriate filing office without the signature of such Loan Party, and (iii) ratifies the filing of any financing statement, and any continuation statement or amendment with respect thereto, filed without the signature of such Loan Party prior to the date hereof. (r) Repayment of Vitabest Obligations. Cause the outstanding obligations of the Borrower under the Vitabest Settlement Agreement to be repaid in full on or prior to July 30, 2025, and cause evidence of such payment, in form and substance reasonably satisfactory to the Administrative Agent, to be delivered to the Administrative Agent on or prior to such date. (s) Lender Warrant. At an annual or special meeting of stockholders of the Borrower, which meeting shall be promptly called and held no later than June 30, 2026, the Borrower shall obtain the Stockholder Warrant Approval (as defined in the Lender Warrant).

Section
7.2. Negative Covenants. So long as any principal of or interest on any Loan or any other Obligation (whether or not due)
shall remain unpaid (other than Contingent Indemnity Obligations) or any Lender shall have any Commitment hereunder, each Loan Party
shall not, unless the Required Lenders shall otherwise consent in writing:

(a) Liens,
Etc. Create, incur, assume or suffer to exist, or permit any of its Subsidiaries to create, incur, assume or suffer to exist, any
Lien upon or with respect to any of its properties, whether now owned or hereafter acquired; file or suffer to exist under the Uniform
Commercial Code or any Requirement of Law of any jurisdiction, a financing statement (or the equivalent thereof) that names it or any
of its Subsidiaries as debtor; sign or suffer to exist any security agreement authorizing any secured party thereunder to file such financing
statement (or the equivalent thereof) other than, as to all of the above, Permitted Liens.

(b) Indebtedness.
Create, incur, assume, guarantee or suffer to exist, or otherwise become or remain liable with respect to, or permit any of its Subsidiaries
to create, incur, assume, guarantee or suffer to exist or otherwise become or remain liable with respect to, any Indebtedness other than
Permitted Indebtedness.

Fundamental Changes; Dispositions.

(i) Wind
up, liquidate or dissolve, or merge, consolidate or amalgamate with any Person, including by means of a “plan of division”
under the Delaware Limited Liability Company Act or any comparable transaction under any similar law, or permit any of its Subsidiaries
to do (or agree to do) any of the foregoing; provided, however, that any wholly-owned Subsidiary of any Loan Party (other than a Borrower)
may be merged into such Loan Party or another wholly-owned Subsidiary of such Loan Party, or may consolidate or amalgamate with another
wholly-owned Subsidiary of such Loan Party, so long as:

no other provision of this Agreement would be violated thereby;

such Loan Party gives the Agents at least thirty (30) days (or such shorter period as the Agents may agree in their sole discretion)
prior written notice of such merger, consolidation or amalgamation accompanied by true, correct and complete copies of all material agreements,
documents and instruments relating to such merger, consolidation or amalgamation, including, without limitation, the certificate or certificates
of merger or amalgamation to be filed with each appropriate Secretary of State (with a copy as filed promptly after such filing);

Default or Event of Default shall have occurred and be continuing either before or after giving effect to such transaction;

(D) the
Lenders’ rights in any Collateral, including, without limitation, the existence, perfection and priority of any Lien thereon, are
not adversely affected by such merger, consolidation or amalgamation; and

(E) the
surviving Subsidiary, if any, if not already a Loan Party, is joined as a Loan Party hereunder pursuant to a Joinder Agreement and is
a party to a Security Agreement and the Equity Interests of such Subsidiary is the subject of a Security Agreement, in each case, which
is in full force and effect on the date of and immediately after giving effect to such merger, consolidation or amalgamation (or such
later date as consented to by the Collateral Agent).

(ii) Make
any Disposition, whether in one transaction or a series of related transactions, of all or any part of its business, property or assets,
whether now owned or hereafter acquired (or agree to do any of the foregoing), or permit any of its Subsidiaries to do any of the foregoing;
provided, however, that any Loan Party and its Subsidiaries may make Permitted Dispositions.

Change in Nature of Business. Make, or permit any of its Subsidiaries to make, any change in the nature of its business as described
in Section 6.1(l).

Loans, Advances, Investments, Etc. Make or commit or agree to make, or permit any of its Subsidiaries make or commit or agree
to make, any Investment in any other Person except for Permitted Investments.

Sale and Leaseback Transactions. Enter into, or permit any of its Subsidiaries to enter into, any Sale and Leaseback Transaction.

Limitation on Issuance of Equity Interests; Subsidiaries.

IssueOther than with respect
to the Lender Warrant, issue or sell or enter into any agreement or arrangement for the issuance and sale of, or permit any of
its Subsidiaries to issue or sell or enter into any agreement or arrangement for the issuance and sale of, any Equity Interests, any
securities convertible into or exchangeable for its Equity Interests or any warrants to acquire its Equity Interests; provided that the
Loan Parties may issue Qualified Equity Interests so long as no Change of Control would result therefrom.

Form any Subsidiary after the Effective Date unless such Subsidiary (i) is a wholly-owned Subsidiary organized under the laws of the
United States, and

complies with the requirements under Section 7.1(b); provided that the formation of any non-wholly-owned Subsidiary shall require the
prior written consent of the Agents.

(iii)
Enter into, after the Effective Date, any partnership, joint venture or similar arrangement from and after the Effective Date without
the prior written consent of the Agents.

(h) Restricted
Payments. Make or permit any of its Subsidiaries to make any Restricted Payment other than Permitted Restricted Payments.

(i) Federal
Reserve Regulations. Permit any Loan or the proceeds of any Loan under this Agreement to be used for any purpose that would cause
such Loan to be a margin loan under the provisions of Regulation T, U or X of the Board of Governors.

(j) Transactions
with Affiliates. Enter into, renew, extend or be a party to, or permit any of its Subsidiaries to enter into, renew, extend or be
a party to, any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer or
exchange of property or assets of any kind or the rendering of services of any kind) with any Affiliate, except (i) transactions consummated
in the ordinary course of business in a manner and to an extent consistent with past practice and necessary or desirable for the prudent
operation of its business, for fair consideration and on terms no less favorable to it or its Subsidiaries than would be obtainable in
a comparable arm’s length transaction with a Person that is not an Affiliate thereof, and that are fully disclosed to the Agents
prior to the consummation thereof, (ii) transactions with another Loan Party, (iii) transactions permitted by Sections 7.2(e), 7.2(g)
and 7.2(h), (iv) sales of Qualified Equity Interests of the Borrower to Affiliates of the Borrower not otherwise prohibited by the Loan
Documents and the granting of registration and other customary rights in connection therewith, (v) reasonable and customary director
and officer compensation (including bonuses and stock option programs), benefits and indemnification arrangements, in each case approved
by the Board of Directors (or a committee thereof) of such Loan Party or such Subsidiary, and (vi) the transactions with Affiliates existing
on the Effective Date and described on Schedule 7.2(j).

(k) Limitations
on Dividends and Other Payment Restrictions Affecting Subsidiaries. Create or otherwise cause, incur, assume, suffer or permit to
exist or become effective any consensual encumbrance or restriction of any kind on the ability of any Subsidiary of any Loan Party (i)
to pay dividends or to make any other distribution on any shares of Equity Interests of such Subsidiary owned by any Loan Party or any
of its Subsidiaries, (ii) to pay or prepay or to subordinate any Indebtedness owed to any Loan Party or any of its Subsidiaries, (iii)
to make loans or advances to any Loan Party or any of its Subsidiaries or (iv) to transfer any of its property or assets to any Loan
Party or any of its Subsidiaries, or permit any of its Subsidiaries to do any of the foregoing; provided, however, that nothing in any
of clauses (i) through (iv) of this Section 7.2(k) shall prohibit or restrict compliance with:

this Agreement and the other Loan Documents;

[reserved];